216 related articles for article (PubMed ID: 28409480)
1. Genetic Testing for Opioid Pain Management: A Primer.
Agarwal D; Udoji MA; Trescot A
Pain Ther; 2017 Jun; 6(1):93-105. PubMed ID: 28409480
[TBL] [Abstract][Full Text] [Related]
2. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
3. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
4. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
5. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
[TBL] [Abstract][Full Text] [Related]
6. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of chronic pain management.
Kapur BM; Lala PK; Shaw JL
Clin Biochem; 2014 Sep; 47(13-14):1169-87. PubMed ID: 24912048
[TBL] [Abstract][Full Text] [Related]
8. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
9. Reduction in Schedule II opioid prescribing by primary care -providers, orthopedic and general surgeons, and pain -management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force.
Shields LBE; Johnson TA; Daniels MW; Bell A; Siemens DM; Jennings JT; Hester ST; Honaker JT
J Opioid Manag; 2021; 17(2):155-167. PubMed ID: 33890279
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Primary Care Physician Chronic Pain Management Practice Patterns.
Provenzano DA; Kamal KM; Giannetti V
Pain Physician; 2018 Nov; 21(6):E593-E602. PubMed ID: 30508990
[TBL] [Abstract][Full Text] [Related]
11. Does Preoperative Pharmacogenomic Testing of Patients Undergoing TKA Improve Postoperative Pain? A Randomized Trial.
Kraus MB; Bingham JS; Kekic A; Erickson C; Grilli CB; Seamans DP; Upjohn DP; Hentz JG; Clarke HD; Spangehl MJ
Clin Orthop Relat Res; 2024 Feb; 482(2):291-300. PubMed ID: 37594401
[TBL] [Abstract][Full Text] [Related]
12. Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients.
Reizine N; Danahey K; Schierer E; Liu P; Middlestadt M; Ludwig J; Truong TM; van Wijk XMR; Yeo KJ; Malec M; Ratain MJ; O'Donnell PH
Oncologist; 2021 Nov; 26(11):e2042-e2052. PubMed ID: 34423496
[TBL] [Abstract][Full Text] [Related]
13. Primary care physicians' perspectives on Veterans who obtain prescription opioids from multiple healthcare systems.
Bixler FR; Radomski TR; Zickmund SL; Roman KM; Hausmann LRM; Thorpe CT; Hale JA; Sileanu FE; Gellad WF
J Opioid Manag; 2019; 15(3):183-191. PubMed ID: 31343720
[TBL] [Abstract][Full Text] [Related]
14. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL
J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955
[TBL] [Abstract][Full Text] [Related]
15. Implications of opioid analgesia for medically complicated patients.
Smith H; Bruckenthal P
Drugs Aging; 2010 May; 27(5):417-33. PubMed ID: 20450239
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.
Hajj A; Khabbaz L; Laplanche JL; Peoc'h K
Pharmacogenomics; 2013 Apr; 14(5):575-85. PubMed ID: 23556453
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic considerations in opioid analgesia.
Vuilleumier PH; Stamer UM; Landau R
Pharmgenomics Pers Med; 2012; 5():73-87. PubMed ID: 23226064
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Chronic, Noncancer Pain Management Initiative in a Multidisciplinary Pain Clinic.
Panicker L; Prasun MA; Stockmann C; Simon J
Pain Manag Nurs; 2022 Apr; 23(2):122-127. PubMed ID: 34756689
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]